Recently, brain derived neurotrophic factor (BDNF), dipeptidyl peptidase-4 (DPP4), and Ca2+ brain dysregulation were identified as novel biomarkers and potential therapeutic targets for diabetes-related cognitive impairment [91,92]. This evidence concerns the gene DPP4 and diabetes mellitus.